Literature DB >> 25955736

Diagnosis and management of generalized anxiety disorder and panic disorder in adults.

Amy B Locke1, Nell Kirst1, Cameron G Shultz1.   

Abstract

Generalized anxiety disorder (GAD) and panic disorder (PD) are among the most common mental disorders in the United States, and they can negatively impact a patient's quality of life and disrupt important activities of daily living. Evidence suggests that the rates of missed diagnoses and misdiagnosis of GAD and PD are high, with symptoms often ascribed to physical causes. Diagnosing GAD and PD requires a broad differential and caution to identify confounding variables and comorbid conditions. Screening and monitoring tools can be used to help make the diagnosis and monitor response to therapy. The GAD-7 and the Severity Measure for Panic Disorder are free diagnostic tools. Successful outcomes may require a combination of treatment modalities tailored to the individual patient. Treatment often includes medications such as selective serotonin reuptake inhibitors and/or psychotherapy, both of which are highly effective. Among psychotherapeutic treatments, cognitive behavior therapy has been studied widely and has an extensive evidence base. Benzodiazepines are effective in reducing anxiety symptoms, but their use is limited by risk of abuse and adverse effect profiles. Physical activity can reduce symptoms of GAD and PD. A number of complementary and alternative treatments are often used; however, evidence is limited for most. Several common botanicals and supplements can potentiate serotonin syndrome when used in combination with antidepressants. Medication should be continued for 12 months before tapering to prevent relapse.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25955736

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  29 in total

1.  Association between suicide death and concordance with benzodiazepine treatment guidelines for anxiety and sleep disorders.

Authors:  Jennifer M Boggs; Richard C Lindrooth; Catherine Battaglia; Arne Beck; Debra P Ritzwoller; Brian K Ahmedani; Rebecca C Rossom; Frances L Lynch; Christine Y Lu; Beth E Waitzfelder; Ashli A Owen-Smith; Gregory E Simon; Heather D Anderson
Journal:  Gen Hosp Psychiatry       Date:  2019-11-17       Impact factor: 3.238

Review 2.  Benzodiazepine Use, Misuse, and Harm at the Population Level in Canada: A Comprehensive Narrative Review of Data and Developments Since 1995.

Authors:  Yoko Murphy; Emily Wilson; Elliot M Goldner; Benedikt Fischer
Journal:  Clin Drug Investig       Date:  2016-07       Impact factor: 2.859

3.  Screening for postpartum anxiety: A quality improvement project to promote the screening of women suffering in silence.

Authors:  Sarah Toler; Susan Stapleton; Kim Kertsburg; Tiffany J Callahan; Marie Hastings-Tolsma
Journal:  Midwifery       Date:  2018-04-03       Impact factor: 2.372

4.  Evaluation of MINOCA syndrome and HEART score in patients presenting to the emergency department with panic attack and chest pain complaints.

Authors:  Bahadır Taslidere; Ahmet Atsiz
Journal:  Ir J Med Sci       Date:  2022-04-28       Impact factor: 2.089

Review 5.  Assessment of mental health in patients with chronic liver disease.

Authors:  Maureen P Whitsett; Arpita Goswami Banerjee; Marina Serper
Journal:  Clin Liver Dis (Hoboken)       Date:  2022-07-16

Review 6.  Withdrawing Benzodiazepines in Patients With Anxiety Disorders.

Authors:  Malcolm Lader; Andri Kyriacou
Journal:  Curr Psychiatry Rep       Date:  2016-01       Impact factor: 5.285

7.  Patterns of anticonvulsant use and adverse drug events in older adults.

Authors:  Lidia M V R Moura; Jason R Smith; Zhiyu Yan; Deborah Blacker; Lee H Schwamm; Joseph P Newhouse; Sonia Hernandez-Diaz; John Hsu
Journal:  Pharmacoepidemiol Drug Saf       Date:  2020-10-02       Impact factor: 2.890

8.  Benzodiazepine Use in the USA Is Driven by Long-term Users: a Repeated Cross-sectional Study of MEPS 2002-2016.

Authors:  Michael E Johansen; Joshua D Niforatos
Journal:  J Gen Intern Med       Date:  2019-05-01       Impact factor: 5.128

9.  Global, regional and national burden of anxiety disorders from 1990 to 2019: results from the Global Burden of Disease Study 2019.

Authors:  Xiaorong Yang; Yuan Fang; Hui Chen; Tongchao Zhang; Xiaolin Yin; Jinyu Man; Lejin Yang; Ming Lu
Journal:  Epidemiol Psychiatr Sci       Date:  2021-05-06       Impact factor: 6.892

10.  Assessing Primary Care Contributions to Behavioral Health: A Cross-sectional Study Using Medical Expenditure Panel Survey.

Authors:  Anuradha Jetty; Stephen Petterson; John M Westfall; Yalda Jabbarpour
Journal:  J Prim Care Community Health       Date:  2021 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.